home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Susceptibility to Bladder Cancer

  September, 18 2008 8:24
your information resource in human molecular genetics

Researchers have found a genetic variant associated with increased risk of urinary bladder cancer, according to a study published online in Nature Genetics.

One of the more tantalizing stories to emerge from recent genetic association studies of cancer has been that a series of variants in a small region on chromosome 8 predispose to a range of cancers, including those of the prostate, colon and breast.

Kari Stefansson and colleagues carried out a genome-wide association study of bladder cancer, and found a variant in the same region to confer extra risk of this disease, but not of any of the other cancers. The previously reported variants are near the gene MYC, which encodes a protein whose deregulation is known to be associated with malignant growth. The susceptibility variant for bladder cancer is even closer to MYC, strengthening the case that these risk variants might affect cancer risk by altering the expression of MYC.

The team was unable to find functional evidence for altered MYC expression in blood or fat tissue from individuals with bladder cancer, however, indicating that further work will be needed to explain the role of this region in cancer susceptibility.

Author contact:

Kari Stefansson (deCODE Genetics, Reykjavik, Iceland)
E-mail: kstefans@decode.is

Abstract available online.

(C) Nature Genetics press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.